It is all about the specificity of the test.We all want an...

  1. 251 Posts.
    lightbulb Created with Sketch. 9
    It is all about the specificity of the test.

    We all want an ovarian cancer test for what is an awful disease.

    You see 97% is not good enough if you need to be 99.5% correct to avoid a false positive.
    http://www.ovariancancer.jhmi.edu/ca125qa.cfm


    This is the reason that the FDA has banned this panel testing.

    Sorry guys, don't want to see anybody burnt. There isn't real here. I wish it was real both for investors and for cancer sufferors.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.